These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24051124)

  • 1. A long acting biodegradable controlled delivery of chitosan microspheres loaded with tetanus toxoide as model antigen.
    Varma S; Sadasivan C
    Biomed Pharmacother; 2014 Mar; 68(2):225-30. PubMed ID: 24051124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
    Pirouzmand H; Khameneh B; Tafaghodi M
    Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-HPMC-blended microspheres as a vaccine carrier for the delivery of tetanus toxoid.
    Arthanari S; Mani G; Peng MM; Jang HT
    Artif Cells Nanomed Biotechnol; 2016; 44(2):517-23. PubMed ID: 25472756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of basic fibroblast growth factor chitosan microsphere and its properties].
    Chen W; Liu Z; Yue Y; Wan L; Hu J; Lü B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Aug; 26(8):989-92. PubMed ID: 23012937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of chitosan microspheres for tetanus, diphtheria and divalent vaccines: a comparative study of subcutaneous and intranasal administration in mice.
    Hashem FM; Fahmy SA; El-Sayed AM; Al-Sawahli MM
    Pharm Dev Technol; 2013; 18(5):1175-85. PubMed ID: 21985525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
    Anal AK; Stevens WF; Remuñán-López C
    Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
    Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
    J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
    Katare YK; Panda AK
    Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
    Wang LY; Gu YH; Su ZG; Ma GH
    Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug.
    Wang LY; Ma GH; Su ZG
    J Control Release; 2005 Aug; 106(1-2):62-75. PubMed ID: 15922472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical cross-linking: A feasible approach to prolong doxylamine/pyridoxine release from spray-dried chitosan microspheres.
    Katsarov P; Pilicheva B; Uzunova Y; Gergov G; Kassarova M
    Eur J Pharm Sci; 2018 Oct; 123():387-394. PubMed ID: 30077710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
    Gu YH; Wang LY; Tan TW; Ma GH
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
    Cai J; Zhang Y; Du W; Nan K
    J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
    [No Abstract]   [Full Text] [Related]  

  • 17. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.
    Gupta KC; Jabrail FH
    Carbohydr Res; 2006 May; 341(6):744-56. PubMed ID: 16499893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of superoxide dismutase loaded chitosan microspheres: characterization and release studies.
    Celik O; Akbuğa J
    Eur J Pharm Biopharm; 2007 Apr; 66(1):42-7. PubMed ID: 17055712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillaja saponins after nasal immunization in rabbit.
    Mohaghegh M; Tafaghodi M
    Pharm Dev Technol; 2011 Feb; 16(1):36-43. PubMed ID: 20082579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive modeling of insulin release profile from cross-linked chitosan microspheres.
    Jose S; Fangueiro JF; Smitha J; Cinu TA; Chacko AJ; Premaletha K; Souto EB
    Eur J Med Chem; 2013 Feb; 60():249-53. PubMed ID: 23313633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.